Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
about
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XLA Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake InhibitorGetting the balance right: Established and emerging therapies for major depressive disordersImproved Health-Related Quality of Life and Reduced Productivity Loss After Treatment With Bupropion Sustained Release: A Study in Patients With Major DepressionBupropion: a systematic review and meta-analysis of effectiveness as an antidepressantEVITA: a tool for the early evaluation of pharmaceutical innovations with regard to therapeutic advantageClinic visits in late-life depression trials: effects on signal detection and therapeutic outcome.Reconsidering anhedonia in depression: lessons from translational neuroscience.Pharmacotherapy to sustain the fully remitted state.The Many Uses of Bupropion and Bupropion Sustained Release (SR) in AdultsA primary care focus on the treatment of patients with major depressive disorder.Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study.A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.Huanglian-Jie-Du-Tang Extract Ameliorates Depression-Like Behaviors through BDNF-TrkB-CREB Pathway in Rats with Chronic Unpredictable Stress.Comparative Effectiveness of Antidepressant Medication versus Psychological Intervention on Depression Symptoms in Women with Infertility and Sexual Dysfunction.
P2860
Q24530904-C061904B-5EEF-49C5-8DF9-2A9610CC74ADQ24563250-B79575B1-4E23-41BA-9977-9F8FC3C2C68FQ24610225-D4FEE521-8A11-4EFD-BCD5-63492AF4781BQ24683006-3D68888B-7DFE-4FDA-A3CD-1BE29B7863CAQ26747727-61AAE62D-CBEC-4A40-A451-415E2F2FCD02Q33541294-1D021126-26AB-4925-A0E2-6DCF88007061Q33563618-3A69B8A4-75B6-4FE8-A4CB-1C932704908DQ34124371-BFB6D47D-605E-4065-A4D3-8864B7F4EDBFQ34783161-C9401A1B-0CA5-4CC3-8AE6-8BED2953FDE6Q35128505-E7113B8E-DEA2-4CC4-987D-1062F6C1ABCEQ35207313-EAC81E0A-B8DB-459B-946C-53BDC1BA6371Q35549106-0F89349F-2992-413D-A8DC-4481B272A1A4Q35567191-C68DEF44-64E4-4DA3-90CD-F6764607DD9AQ37653402-E2216753-D1EB-4B16-9585-186266A34C99Q41019012-F9AF7755-3AD8-45E8-9250-EBD12CC275F6Q47655414-3034302D-4335-41B8-B576-B930AA05D205
P2860
Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Bupropion sustained release ve ...... of depression in the elderly.
@en
Bupropion sustained release ve ...... of depression in the elderly.
@nl
type
label
Bupropion sustained release ve ...... of depression in the elderly.
@en
Bupropion sustained release ve ...... of depression in the elderly.
@nl
prefLabel
Bupropion sustained release ve ...... of depression in the elderly.
@en
Bupropion sustained release ve ...... of depression in the elderly.
@nl
P2093
P1476
Bupropion sustained release ve ...... of depression in the elderly.
@en
P2093
P304
P577
2000-03-01T00:00:00Z